help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 5, 2003, doi:10.1164/rccm.200208-950OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200208-950OCv1
167/12/1641    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherwood, E. R.
Right arrow Articles by Varma, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherwood, E. R.
Right arrow Articles by Varma, T. K.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1641-1649, (2003)
© 2003 American Thoracic Society


Original Article

ß2 Microglobulin Knockout Mice Are Resistant to Lethal Intraabdominal Sepsis

Edward R. Sherwood, Cheng Y. Lin, Weike Tao, Christopher A. Hartmann, Jay E. Dujon, Andrew J. French and Tushar K. Varma

Department of Anesthesiology, University of Texas Medical Branch, Shriners Hospital for Children, Galveston, Texas

Correspondence and requests for reprints should be addressed to Edward R. Sherwood, M.D., Department of Anesthesiology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0591. E-mail: ersherwo{at}utmb.edu

ß2 microglobulin knockout (ß2M-/-) mice lack CD8+ T and natural killer T cells. We hypothesized that ß2M-/- mice are resistant to lethal intraabdominal sepsis. To test this hypothesis, mortality, cytokine production, and physiologic function were assessed in ß2M-/- mice during sepsis caused by cecal ligation and puncture (CLP). ß2M-/- mice survived significantly longer than wild-type mice after CLP but ultimately exhibited 100% mortality. Treatment of ß2M-/- mice with anti-asialoGM1 to deplete natural killer cells conferred greater than 70% long-term survival. Compared with wild-type mice, ß2M-/- mice treated with anti-asialoGM1 produced decreased amounts of proinflammatory cytokines and did not exhibit hypothermia or metabolic acidosis after CLP. Adoptive transfer of CD8+ T and natural killer cells into ß2M-/- mice treated with anti-asialoGM1 re-established CLP-induced mortality. CD8 knockout mice treated with anti-asialoGM1, which are specifically deficient in CD8+ T and natural killer cells, exhibited 40% long-term survival after CLP. Furthermore, treatment of wild-type mice with antibodies to CD8 and asialoGM1 conferred a significant survival benefit compared with wild-type mice treated with nonspecific IgG. These findings demonstrate that ß2M-/- mice treated with anti-asialoGM1 are resistant to CLP-induced mortality and that depletion of CD8+ T and natural killer cells largely accounts for the survival benefit observed in these mice.

Key Words: CD8+ T lymphocytes • natural killer cells • septic shock




This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. L. Cogen and T. A. Moore
{beta}2-Microglobulin-Dependent Bacterial Clearance and Survival during Murine Klebsiella pneumoniae Bacteremia
Infect. Immun., January 1, 2009; 77(1): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. O. Etogo, J. Nunez, C. Y. Lin, T. E. Toliver-Kinsky, and E. R. Sherwood
NK but Not CD1-Restricted NKT Cells Facilitate Systemic Inflammation during Polymicrobial Intra-Abdominal Sepsis
J. Immunol., May 1, 2008; 180(9): 6334 - 6345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. E. Wesche-Soldato, C.-S. Chung, S. H. Gregory, T. P. Salazar-Mather, C. A. Ayala, and A. Ayala
CD8+ T Cells Promote Inflammation and Apoptosis in the Liver after Sepsis: Role of Fas-FasL
Am. J. Pathol., July 1, 2007; 171(1): 87 - 96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. T. Enoh, C. D. Fairchild, C. Y. Lin, T. K. Varma, and E. R. Sherwood
Differential effect of imipenem treatment on wild-type and NK cell-deficient CD8 knockout mice during acute intra-abdominal injury
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R685 - R693.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. T. Enoh, C. Y. Lin, T. K. Varma, and E. R. Sherwood
Differential effect of imipenem treatment on injury caused by cecal ligation and puncture in wild-type and NK cell-deficient {beta}2-microgloblin knockout mice
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G277 - G284.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Tao, V. T. Enoh, C. Y. Lin, W. E. Johnston, P. Li, and E. R. Sherwood
Cardiovascular dysfunction caused by cecal ligation and puncture is attenuated in CD8 knockout mice treated with anti-asialoGM1
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R478 - R485.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. E. Toliver-Kinsky, W. Cui, E. D. Murphey, C. Lin, and E. R. Sherwood
Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection
J. Immunol., January 1, 2005; 174(1): 404 - 410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. Pravinkumar and E. R. Sherwood
Balance of Inflammation in Sepsis
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 655 - 656.
[Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Tao and E. R. Sherwood
{beta}2-Microglobulin knockout mice treated with anti-asialoGM1 exhibit improved hemodynamics and cardiac contractile function during acute intra-abdominal sepsis
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R569 - R575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 239 - 253.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  Membership Renewal